EUVIMEDEUVIMED entdecken
Crossref

Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease

Evidence-based Healthcare · 2003

DOI: 10.1016/j.ehbc.2003.08.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Evidence-based Healthcare, 2003. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2003). Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease. Evidence-based Healthcare. https://doi.org/10.1016/j.ehbc.2003.08.001

Vancouver

Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease. Evidence-based Healthcare. 2003. doi:10.1016/j.ehbc.2003.08.001

BibTeX
@article{euvimed2003,
  title = {Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease},
  journal = {Evidence-based Healthcare},
  year = {2003},
  doi = {10.1016/j.ehbc.2003.08.001}
}
Kostenlos starten →